Paul Tudor Jones’s ICU Medical ICUI Stock Holding History

Paul Tudor Jones’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,200	Closed	-$346K	–	2668
2022 Q4	$346K	Buy	+2,200	New	+$335K	0.01%	1809

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paul Tudor Jones's ICUI Position: Q3 2025 in Review

Paul Tudor Jones sold out of ICU Medical (ICUI) in Q3 2025, closing a stake of 2,109 shares — an estimated $279K sold.

Paul Tudor Jones first reported a position in ICUI in Q2 2013 and held it in 27 quarters. The position peaked at $5.49M in Q3 2014. 270 funds tracked by Wall St. Rank hold ICUI as of Q3 2025.

Paul Tudor Jones reported no remaining ICU Medical position as of Q3 2025 after selling out during the quarter.
Paul Tudor Jones sold 2,109 ICU Medical shares in Q3 2025, an estimated $279K.
Paul Tudor Jones first reported a position in ICU Medical in Q2 2013 and held it in 27 quarters.
Paul Tudor Jones's ICU Medical position peaked at $5.49M in Q3 2014.
270 funds tracked by Wall St. Rank held ICU Medical as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.